Emgality® (galcanezumab-gnlm)
for Migraine

Emgality (galcanezumab-gnlm) is a prescription injection used to prevent migraines and treat episodic cluster headaches in adults. It works by blocking calcitonin gene-related peptide (CGRP), a protein involved in causing migraine and cluster headache attacks. By targeting CGRP, Emgality helps reduce the number of migraine days per month and the frequency of cluster headache attacks.

Heart
Medication Guide Icon Medication Guide
TV Commercial Icon TV Commercial
Patient Website Icon Patient Website
Efficacy Data Icon Efficacy Data
New Articles Icon New Articles
Savings and Support Icon Savings and Support
Company MD Payments Icon Company MD Payments
Clinical Trials Icon Clinical Trials
Adverse Event Report Icon Adverse Event Report
Other top medicines used to treat Migraine